المؤلفون: Sigurður Guðjónsson

مصطلحات موضوعية: Cell transformation, neoplastic -- genetics, Gene expression profiling, Gene expression regulation, neoplastic, Neoplasm recurrence, local -- genetics, Neoplasms, multiple primary -- genetics, In situ hybridization, fluorescence, Urinary bladder neoplasms -- genetics, Urinary bladder neoplasms -- pathology, Urinary bladder neoplasms -- drug therapy, Urinary bladder neoplasms -- surgery, Antibiotics, antineoplastic -- therapeutic use, Epirubicin -- therapeutic use, Bladder cancer, Non-muscle-invasive, Recurrence, Biomarkers, Biopsies, Early instillation, Tissue microarray, Gene expression

Degree: Diss. Lund : Lunds universitet, 2010

المؤلفون: Evandro de Azambuja, Sherene Loi, Martine Piccart, Denis Larsimont, Angelo Di Leo, Marianne Paesmans, Ivana Bozovic-Spasojevic, Lieveke Ameye, Stella Dolci

المصدر: Breast, 23 (4

مصطلحات موضوعية: Oncology, Carcinoma, Lobular -- drug therapy -- metabolism -- pathology, medicine.medical_treatment, Antibiotics, Antineoplastic -- therapeutic use, Expression, Carcinoma, Ductal, Breast -- drug therapy -- metabolism -- pathology, Breast cancer, Antineoplastic Combined Chemotherapy Protocols, Tumor Markers, Biological -- metabolism, TP53, Antibiotics, Antineoplastic, Breast Neoplasms -- drug therapy -- metabolism -- pathology, Carcinoma, Ductal, Breast, General Medicine, Middle Aged, Prognosis, Primary tumor, medicine.anatomical_structure, Treatment Outcome, Proto-Oncogene Proteins c-bcl-2, Cisplatin -- therapeutic use, Chemotherapy, Adjuvant, Female, Fluorouracil, Adjuvant, Adult, medicine.medical_specialty, BCL2, Randomization, Axillary lymph nodes, Anthracycline, Concordance, Breast Neoplasms, Antineoplastic Combined Chemotherapy Protocols -- therapeutic use, Disease-Free Survival, Internal medicine, Epirubicin -- therapeutic use, medicine, Methotrexate -- therapeutic use, Tumor Suppressor Protein p53 -- metabolism, Biomarkers, Tumor, Humans, Chirurgie, neoplasms, Aged, Epirubicin, Retrospective Studies, Gynecology, Chemotherapy, Proto-Oncogene Proteins c-bcl-2 -- metabolism, business.industry, Fluorouracil -- therapeutic use, medicine.disease, Carcinoma, Lobular, Methotrexate, Axilla, Surgery, Lymph Nodes, Cisplatin, Tumor Suppressor Protein p53, business, Lymph Nodes -- metabolism -- pathology, Biomarkers

وصف الملف: 2 full-text file(s): application/pdf; application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3707fe5d6d6dc6189a80dc913e1039a
https://pubmed.ncbi.nlm.nih.gov/24768477

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Fountzilas, G., Nicolaides, C., Aravantinos, G., Skarlos, D., Kosmidis, P., Papakostas, P., Stathopoulos, G. P., Kontostolis, E., Bafaloukos, D., Pavlidis, N.

مصطلحات موضوعية: Adult, Dose-Response Relationship, Drug, Epirubicin/*therapeutic use, Middle Aged, Combined Modality Therapy, Drug Administration Schedule, Granulocyte Colony-Stimulating Factor/therapeutic use, Lymphatic Metastasis, Antibiotics, Antineoplastic/*therapeutic use, Feasibility Studies, Humans, Female, Breast Neoplasms/*drug therapy/*surgery, Aged, Follow-Up Studies

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od_____10561::5f36d2915837441ede462d0e10e5d557
http://olympias.lib.uoi.gr/jspui/handle/123456789/22357

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Bozovic-Spasojevic, Ivana, Ameye, Lieveke, Paesmans, Marianne, Larsimont, Denis, Di Leo, Angelo, Dolci, Stella, Azambuja, Evandro, Piccart-Gebhart, Martine, Loi, Sherene

المصدر: Breast, 23 (4

مصطلحات الفهرس: Chirurgie, Adult, Aged, Antibiotics, Antineoplastic -- therapeutic use, Antineoplastic Combined Chemotherapy Protocols -- therapeutic use, Axilla, Breast Neoplasms -- drug therapy -- metabolism -- pathology, Carcinoma, Ductal, Breast -- drug therapy -- metabolism -- pathology, Carcinoma, Lobular -- drug therapy -- metabolism -- pathology, Chemotherapy, Adjuvant, Cisplatin -- therapeutic use, Disease-Free Survival, Epirubicin -- therapeutic use, Female, Fluorouracil -- therapeutic use, Humans, Lymph Nodes -- metabolism -- pathology, Methotrexate -- therapeutic use, Middle Aged, Prognosis, Proto-Oncogene Proteins c-bcl-2 -- metabolism, Retrospective Studies, Treatment Outcome, Tumor Markers, Biological -- metabolism, Tumor Suppressor Protein p53 -- metabolism, BCL2, Biomarkers, Breast cancer, Expression, TP53, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article

URL: https://dipot.ulb.ac.be/dspace/bitstream/2013/187913/4/doi_171540.pdf
https://dipot.ulb.ac.be/dspace/bitstream/2013/187913/1/Elsevier_171540.pdf
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/187913
http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL

المؤلفون: Moretti, Erica, Desmedt, Christine, Biagioni, Chiara, Regan, Meredith M, Oakman, Catherine, Larsimont, Denis, Galardi, Francesca, Piccart-Gebhart, Martine, Sotiriou, Christos, Rimm, David D.L., Di Leo, Angelo

المصدر: Future oncology, 9 (10

مصطلحات الفهرس: Cancérologie, Médecine pathologie humaine, Sciences bio-médicales et agricoles, Antigens, Neoplasm -- genetics -- metabolism, Antineoplastic Agents -- therapeutic use, Breast Neoplasms -- drug therapy -- metabolism -- mortality, Cell Nucleus -- metabolism, Cytoplasm -- metabolism, DNA Topoisomerases, Type II -- genetics -- metabolism, DNA-Binding Proteins -- genetics -- metabolism, Epirubicin -- therapeutic use, Female, Humans, Immunohistochemistry, Neoadjuvant Therapy, Prognosis, Protein Transport, Topoisomerase II Inhibitors -- therapeutic use, anthracyclines, biomarker, breast cancer, quantitative immunofluorescence, TOP2A, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article

URL: http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/153435
http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL

المؤلفون: Praga, Claudio, Bergh, Jonas, Bliss, Judith M, Bonneterre, J, Cesana, Bruno, Coombes, Raoul Charles, Fargeot, Pierre, Folin, Annika, Fumoleau, Pierre, Giuliani, Rosa, Kerbrat, Pierre, Hery, Michel, Nilsson, Jonas, Onida, Francesco, Piccart-Gebhart, Martine, Shepherd, L, Therasse, P., Wils, J, Rogers, David

المصدر: Journal of clinical oncology, 23 (18

مصطلحات الفهرس: Sciences bio-médicales et agricoles, Adult, Antineoplastic Combined Chemotherapy Protocols -- adverse effects, Breast Neoplasms -- drug therapy, Chemotherapy, Adjuvant -- adverse effects, Cyclophosphamide -- adverse effects, Cyclophosphamide -- therapeutic use, Data Interpretation, Statistical, Epirubicin -- adverse effects, Epirubicin -- therapeutic use, Female, Follow-Up Studies, Humans, Leukemia, Myeloid, Acute -- chemically induced, Middle Aged, Myelodysplastic Syndromes -- chemically induced, Randomized Controlled Trials as Topic, Risk Factors, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article

URL: http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/55389
http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL